PomDoctor Limited (POM)

Revance Therapeutics Statistics

Total Valuation

PomDoctor has a market cap or net worth of $592.22 million. The enterprise value is $655.94 million.

Market Cap	592.22M
Enterprise Value	655.94M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

PomDoctor has 118.44 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	118.44M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.15
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	14.57
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$292,353
Profits Per Employee	-$123,333
Employee Count	154
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PomDoctor had revenue of $45.02 million and -$18.99 million in losses. Loss per share was -$0.16.

Revenue	45.02M
Gross Profit	6.03M
Operating Income	-2.55M
Pretax Income	-19.14M
Net Income	-18.99M
EBITDA	n/a
EBIT	n/a
Loss Per Share	-$0.16

Balance Sheet

The company has $1.93 million in cash and $65.65 million in debt, giving a net cash position of -$63.72 million or -$0.54 per share.

Cash & Cash Equivalents	1.93M
Total Debt	65.65M
Net Cash	-63.72M
Net Cash Per Share	-$0.54
Equity (Book Value)	-303.22M
Book Value Per Share	-2.56
Working Capital	n/a

Cash Flow

In the last 12 months, operating cash flow was -$3.75 million and capital expenditures -$17,992, giving a free cash flow of -$3.77 million.

Operating Cash Flow	-3.75M
Capital Expenditures	-17,992
Free Cash Flow	-3.77M
FCF Per Share	-$0.03

Margins

Gross margin is 13.40%, with operating and profit margins of -5.67% and -42.19%.

Gross Margin	13.40%
Operating Margin	-5.67%
Pretax Margin	-42.51%
Profit Margin	-42.19%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-8.37%

Dividends & Yields

PomDoctor does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-3.21%
FCF Yield	-0.64%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a